Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fulgent Genetics, Inc. Director's Dealing 2020

May 28, 2020

32553_dirs_2020-05-27_25d688dc-ac6b-452d-8756-fe7aa4c371ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-05-22

Reporting Person: BOLGER JOHN C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-22 Common Stock M 2500 $3.925 Acquired 9342 Direct
2020-05-22 Common Stock M 2631 $0.38 Acquired 11973 Direct
2020-05-22 Common Stock S 8677 $15.3611 Disposed 3296 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-22 Stock Option (Right to Buy) $3.925 M 2500 Disposed 2028-05-18 Common Stock (2500) Direct
2020-05-22 Stock Option (Right to Buy) $0.38 M 2631 Disposed 2026-02-22 Common Stock (2631) Direct
2020-05-27 Stock Option (Right to Buy) $15.82 A 5000 Acquired 2030-05-26 Common Stock (5000) Direct

Footnotes

F1: The shares were sold in multiple transactions at prices ranging from $15.29 to $15.48, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.

F3: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after February 23, 2016, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.

F4: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.